Skip to main content

Advertisement

Log in

Non-Adherence and Graft Failure in Adult Liver Transplant Recipients

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Non-adherence to medical therapy after liver transplantation is confounded by different methods of measurement.

Aims

(1) To compare the performance of three different methods of measuring non-adherence: (a) biochemical (standard deviation [SD] tacrolimus levels), (b) clinician report, (c) self-report. (2) To identify pre-transplant predictors of post-transplant non-adherence. (3) To evaluate whether SD tacrolimus is an accurate predictor of graft outcomes.

Methods

In this retrospective cohort study, charts of adult recipients of a liver transplant 2003–2009 (sample A, n = 444) were reviewed to determine pre-transplant predictors of non-adherence and clinician report of non-adherence. SD tacrolimus levels were measured between 6 and 18 months post-transplant. A subset of sample A (n = 122) completed a survey on non-adherence. The three methods were compared using linear and logistic regression. Multivariable analysis was used to investigate pre-transplant predictors of non-adherence. In sample B (transplant recipients 1995–2003, n = 544) Cox regression was used to determine the relationship between SD immunosuppressant level and graft failure.

Results

Non-adherence was found in 22–62 % of subjects, with the highest rates indicated by self-report. Clinician report of non-adherence was associated with both self-report and SD tacrolimus. On multivariable analysis, unemployment at time of listing and chart evidence of pre-transplant non-adherence were significant predictors of higher SD of tacrolimus. History of substance abuse and pre-transplant chart evidence of non-adherence were also significant independent predictors of post-transplant chart evidence of non-adherence. Drug variability in the immediate post-transplant setting was independently associated with graft failure over time (hazard ratio 1.005 per unit increase in standard deviation, p = 0.04).

Conclusions

Non-adherence among liver transplant recipients is a common problem associated with increased risk of graft failure. SD tacrolimus can be used to measure non-adherent behavior and perhaps target patients for behavioral interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Martin AP, Bartels M, Hauss J, Fangmann J. Overview of the MELD score and the UNOS adult liver allocation system. Trans Proc. 2007;39:3169–3174.

    Article  CAS  Google Scholar 

  2. Volk M. Personal communication. In: Lieber S, ed. City; 2010.

  3. Aranda-Michel J, Dickson RC, Bonatti H, Crossfield JR, Keaveny AP, Vasquez AR. Patient selection for liver transplant: 1-year experience with 555 patients at a single center. Mayo Clinic Proc. 2008;83:165–168.

    Google Scholar 

  4. Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ Couns. 2005;59:13–20.

    Article  PubMed  Google Scholar 

  5. Denhaerynck K, Dobbels F, Cleemput I, et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Trans Int. 2005;18:1121–1133.

    Article  Google Scholar 

  6. Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83:858–873.

    Article  PubMed  Google Scholar 

  7. Lisson GL, Rodrigue JR, Reed AI, Nelson DR. A brief psychological intervention to improve adherence following transplantation. Ann Trans. 2005;10:52–57.

    Google Scholar 

  8. Falkenstein K, Flynn L, Kirkpatrick B, Casa-Melley A, Dunn S. Non-compliance in children post-liver transplant. Who are the culprits? Pediatr Trans. 2004;8:233–236.

    Article  Google Scholar 

  9. Stuber ML, Shemesh E, Seacord D, Washington J III, Hellemann G, McDiarmid S. Evaluating non-adherence to immunosuppressant medications in pediatric liver transplant recipients. Pediatr Trans. 2008;12:284–288.

    Article  Google Scholar 

  10. Venkat VL, Nick TG, Bucuvalas JC, Wang Y. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence. Pediatr Trans. 2008;12:67–72.

    Article  Google Scholar 

  11. Shemesh E, Shneider BL, Savitzky JK, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics. 2004;113:825–832.

    Article  PubMed  Google Scholar 

  12. Morales JM, Varo E, Lazaro P. Immunosuppressant treatment adherence, barriers to adherence and quality of life in renal and liver transplant recipients in Spain. Clin Transpl. 2012;26:369–376.

    Article  Google Scholar 

  13. Drent G, Haagsma EB, Geest SD, et al. Prevalence of prednisolone (non)compliance in adult liver transplant recipients. Transpl Int. 2005;18:960–966.

    Article  PubMed  Google Scholar 

  14. Lamba S, Nagurka R, Desai KK, Chun SJ, Holland B, Koneru B. Self-reported non-adherence to immune-suppressant therapy in liver transplant recipients: demographic, interpersonal, and intrapersonal factors. Clin Transpl. 2012;26:328–335.

    Article  Google Scholar 

  15. Fine RN, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transpl. 2009;9:35–41.

    Article  CAS  Google Scholar 

  16. Osterberg L, Blaschke T. Drug therapy—adherence to medication. N Engl J Med. 2005;353:487–497.

    Article  PubMed  CAS  Google Scholar 

  17. Dobbels F, Vanhaecke J, Dupont L, et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation. 2009;87:1497–1504.

    Article  PubMed  Google Scholar 

  18. Chisholm MA. Enhancing transplant patients’ adherence to medication therapy. Clin Transpl. 2002;16:30–38.

    Article  Google Scholar 

  19. Drent G, De Geest S, Haagsma EB. Prednisolone noncompliance and outcome in liver transplant recipients. Transpl Int. 2006;19:342–343.

    Article  PubMed  Google Scholar 

  20. Telles-Correia D, Barbosa A, Mega I, Monteiro E. Psychosocial predictors of adherence after liver transplant in a single transplant center in Portugal. Prog Transpl. 2012;22:91–94.

    Article  Google Scholar 

  21. Kung M, Koschwanez HE, Painter L, Honeyman V, Broadbent E. Immunosuppressant nonadherence in heart, liver, and lung transplant patients: associations with medication beliefs and illness perceptions. Transplantation. 2012;93:958–963.

    Article  PubMed  CAS  Google Scholar 

  22. Dew MA, DiMartini AF, Steel J, et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl. 2008;14:159–172.

    Article  PubMed  Google Scholar 

  23. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102:1417–1426.

    Article  PubMed  Google Scholar 

  24. O’Carroll RE, McGregor LM, Swanson V, Masterton G, Hayes PC. Adherence to medication after liver transplantation in Scotland: a pilot study. Liver Transpl. 2006;12:1862–1868.

    Article  PubMed  Google Scholar 

  25. Medical Outcomes Study Social Support Survey (MOSSS). Available at: http://www.rand.org/health/surveys_tools/mos/mos_socialsupport.html. Accessed 7/2010; Sherbourne CD SA. The MOS social support survey. Soc Sci Med. 1991;32:705–714.

    Google Scholar 

  26. Telles-Correia D, Barbosa A, Mega I, Monteiro E. Adherence correlates in liver transplant candidates. Transpl Proc. 2009;41:1731–1734.

    Article  CAS  Google Scholar 

  27. Schafer-Keller P, Steiger J, Bock A, Denhaerynck K, De Geest S. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transpl. 2008;8:616–626.

    Article  CAS  Google Scholar 

  28. Beckebaum S, Iacob S, Sweid D, et al. Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation. Transpl Int. 2011;24:666–675.

    Article  PubMed  CAS  Google Scholar 

  29. Dharancy S, Giral M, Tetaz R, Fatras M, Dubel L, Pageaux GP. Adherence with immunosuppressive treatment after transplantation: results from the French trial PREDICT. Clin Transpl. 2012;26:E293–E299.

    Article  Google Scholar 

  30. Merli M, Di Menna S, Giusto M, et al. Conversion from twice-daily to once-daily tacrolimus administration in liver transplant patient. Transpl Proc. 2010;42:1322–1324.

    Article  CAS  Google Scholar 

  31. Stilley CS, DiMartini AF, de Vera ME, et al. Individual and environmental correlates and predictors of early adherence and outcomes after liver transplantation. Prog Transpl. 2010;20:58–66; quiz 67.

    Google Scholar 

  32. De Bleser L, Matteson M, Dobbels F, Russell C, De Geest S. Interventions to improve medication-adherence after transplantation: a systematic review. Transpl Int. 2009;22:780–797.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sarah R. Lieber.

Appendix: Survey Materials

Appendix: Survey Materials

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lieber, S.R., Volk, M.L. Non-Adherence and Graft Failure in Adult Liver Transplant Recipients. Dig Dis Sci 58, 824–834 (2013). https://doi.org/10.1007/s10620-012-2412-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-012-2412-0

Keywords

Navigation